Hims & Hers Health, Inc. (HIMS) Return on Invested Capital (ROIC): 6.02%
Is Hims & Hers Health, Inc.’s return on invested capital (ROIC) high or low?
Hims & Hers Health, Inc.'s return on invested capital (ROIC) of 6.02% is 162% above its 5-year average of -9.72%, near the high end of its 5-year range (-32.62%–12.68%).
As of Wednesday, June 17, 2026. 35.61% below its 12-month average of 9.35%.
HIMS Return on Invested Capital (ROIC) Chart
HIMS Average Return on Invested Capital (ROIC) Chart
HIMS Current vs Average Return on Invested Capital (ROIC) Chart
HIMS Return on Invested Capital (ROIC) Metrics
RETURN ON INVESTED CAPITAL (ROIC)
6.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
9.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-2.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-9.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-35.61%
CURRENT VS 3Y AVG
+317.52%
CURRENT VS 5Y AVG
+161.92%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
HIMS Competitors' Return on Invested Capital (ROIC)
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $7.02B | 6.02% | 9.35% | -2.77% | -9.72% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.84B | 2.04% | 2.21% | 2.35% | 2.39% |
| Tempus AI, Inc. (TEM)vs › | $8.82B | -10.29% | -59.01% | -58.33% | -53.58% |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.90B | 8.36% | 4.65% | 6.09% | 6.66% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -24.28% | -15.13% | -6.38% | -2.73% |
| Baxter International Inc. (BAX)vs › | $10.57B | -1.79% | -0.86% | -2.61% | 0.30% |
| Revvity, Inc. (RVTY)vs › | $11.29B | 2.82% | 2.97% | 3.42% | 5.50% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.09B | 5.67% | -6.15% | -6.50% | -3.41% |
| Align Technology, Inc. (ALGN)vs › | $12.86B | 9.94% | 9.96% | 10.13% | 11.66% |
| The Cooper Companies, Inc. (COO)vs › | $13.14B | 3.98% | 4.09% | 3.90% | 4.29% |
Capital Efficiency
ROIC
6.0%
ROE
-3.0%
Hims & Hers Health, Inc. Return on Invested Capital (ROIC) Formula & Definition
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Hims & Hers Health, Inc. Return on Invested Capital (ROIC) FAQ
- What is the return on invested capital (ROIC) for Hims & Hers Health, Inc. (HIMS)?
- The return on invested capital (ROIC) for HIMS stock is 6.02%.
- Is Hims & Hers Health, Inc.'s return on invested capital (ROIC) high or low?
- Hims & Hers Health, Inc.'s return on invested capital (ROIC) of 6.02% is 162% above its 5-year average of -9.72%, near the high end of its 5-year range (-32.62%–12.68%).
- What is the TTM average return on invested capital (ROIC) for Hims & Hers Health, Inc. (HIMS)?
- The TTM average return on invested capital (ROIC) for HIMS stock is 9.35%.
- What is the 3Y average return on invested capital (ROIC) for Hims & Hers Health, Inc. (HIMS)?
- The 3Y average return on invested capital (ROIC) for HIMS stock is -2.77%.
- What is the 5Y average return on invested capital (ROIC) for Hims & Hers Health, Inc. (HIMS)?
- The 5Y average return on invested capital (ROIC) for HIMS stock is -9.72%.
Hims & Hers Health, Inc. Return on Invested Capital (ROIC) History
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 6.02% |
| 2024-12-31 | 12.68% |
| 2023-12-31 | -8.32% |
| 2022-12-31 | -21.45% |
| 2021-12-31 | -32.62% |
| 2020-12-31 | -14.64% |
| 2019-12-31 | -140.50% |
Related Metrics
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum